Oppenheimer Maintains Perform Rating on Quality Systems

A report from Oppenheimer reiterates its Perform rating on Quality Systems (NASDAQ: QSII).

The report states, “…if ambulatory is largely a replacement market, then inpatient should be farther along, which weighed on the clinical group. While we believe it is premature to call the top in terms of sales, we believe peak multiples may be behind us."

QSII closed yesterday at $41.82.